About AVT
Browse Articles
Authors
Customer Services

Current Issue

Displaying 14 results:

Letter

Reply to: Danoprevir pharmacokinetic/viral kinetic model for treating chronic HCV – some considerations

Laetitia Canini, Jeremie Guedj, Alan S Perelson

Antiviral Therapy 2016; 21:648-649


Letter

Danoprevir pharmacokinetic/viral kinetic model for treating chronic HCV – some considerations

Nuggehally R Srinivas

Antiviral Therapy 2016; 21:647-648


Case report

Severe cytomegalovirus colitis with highly elevated sIL-2R mimicking aggressive transformation of adult T-cell lymphoma

Rie Tabata, Chiharu Tabata, Ryoji Yasumizu

Antiviral Therapy 2016; 21:641-645


Case report

Successful treatment of rapidly progressing severe fever with thrombocytopenia syndrome with neurological complications using intravenous immunoglobulin and corticosteroid

Uh Jin Kim, Dong-Min Kim, Joon Hwan Ahn, Seung-Ji Kang, Hee-Chang Jang, Kyung-Hwa Park, Sook In Jung

Antiviral Therapy 2016; 21:637-640


Case report

Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis

Alice Trentalange, Andrea Calcagno, Valeria Ghisetti, Cristiana Atzori, Paolo Busolli, Stefano Bonora, Daniele Imperiale

Antiviral Therapy 2016; 21:633-635


Short communication

Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study

Christoph D Spinner, Kristina E Kern, Alexander Zink, Eva Wolf, Annamaria Balogh, Sebastian Noe, Alexander Von Werder, Christiane Schwerdtfeger, Roland M Schmid, Roman Iakoubov

Antiviral Therapy 2016; 21:627-631


Original article

Pharmacokinetics of intravenous peramivir in the airway epithelial lining fluid of healthy volunteers

Yohei Funatsu, Sadatomo Tasaka, Takahiro Asami, Ho Namkoong, Hiroshi Fujiwara, Osamu Iketani, Kazuma Yagi, Yoshifumi Kimizuka, Makoto Ishii, Tomoyasu Nishimura, Haruhiko Ogata, Satoshi Iwata, Tomoko Betsuyaku, Naoki Hasegawa

Antiviral Therapy 2016; 21:621-625


Original article

Emergence of HCV resistance-associated variants in patients failing sofosbuvir-based regimens: an observational cohort

Elisabeth André-Garnier, Olivier Ribeyrol, Jerome Gournay, Bernard Besse, Marianne Coste-Burel, Isabelle Mabille-Archambeaud, Eric Billaud, Charlotte Biron, Solene Pineau, François Raffi, Berthe-Marie Imbert-Marcille

Antiviral Therapy 2016; 21:611-619


Original article

Ledipasvir and sofosbuvir for HCV infection in patients coinfected with HBV

Edward J Gane, Robert H Hyland, Di An, Evguenia S Svarovskaia, Diana Brainard, John G McHutchison

Antiviral Therapy 2016; 21:605-609


Original article

Evaluation of antiviral drug synergy in an infectious HCV system

Billy Lin, Shanshan He, Hyung Joon Yim, T Jake Liang, Zongyi Hu

Antiviral Therapy 2016; 21:595-603


Page:
Copyright © Nucleus Global 2016. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.